Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.

Tiago M de CarvalhoIrene ManDamien GeorgesLopamudra Ray SaraswatiPrince BhandariIshu KatariaMariam SiddiquiRichard MuwongeEric LucasRengaswamy SankaranarayananPartha BasuJohannes BerkhofJohannes A BogaardsIacopo Baussano

Published in: BMJ global health (2023)

Nationwide introduction of single-dose HPV vaccination at age 10 in India is highly likely to be cost-effective whereas extending the number of doses from one to two would have a less favourable profile.

Keyphrases

healthcare
public health
mental health
high grade
health information
risk assessment
climate change
social media